Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Nov 30:10:601710.
doi: 10.3389/fonc.2020.601710. eCollection 2020.

Etiology of Hepatocellular Carcinoma: Special Focus on Fatty Liver Disease

Affiliations
Review

Etiology of Hepatocellular Carcinoma: Special Focus on Fatty Liver Disease

Diwakar Suresh et al. Front Oncol. .

Abstract

Hepatocellular Carcinoma (HCC) is a highly aggressive cancer with mortality running parallel to its incidence and has limited therapeutic options. Chronic liver inflammation and injury contribute significantly to the development and progression of HCC. Several factors such as gender, age, ethnicity, and demographic regions increase the HCC incidence rates and the major risk factors are chronic infection with hepatitis B virus (HBV) or hepatitis C virus (HCV), carcinogens (food contaminants, tobacco smoking, and environmental toxins), and inherited diseases. In recent years evidence highlights the association of metabolic syndrome (diabetes and obesity), excessive alcohol consumption (alcoholic fatty liver disease), and high-calorie intake (nonalcoholic fatty liver disease) to be the prime causes for HCC in countries with a westernized sedentary lifestyle. HCC predominantly occurs in the setting of chronic liver disease and cirrhosis (80%), however, 20% of the cases have been known in patients with non-cirrhotic liver. It is widely believed that there exist possible interactions between different etiological agents leading to the involvement of diverse mechanisms in the pathogenesis of HCC. Understanding the molecular mechanisms of HCC development and progression is imperative in developing effective targeted therapies to combat this deadly disease. Noteworthy, a detailed understanding of the risk factors is also critical to improve the screening, early detection, prevention, and management of HCC. Thus, this review recapitulates the etiology of HCC focusing especially on the nonalcoholic fatty liver disease (NAFLD)- and alcoholic fatty liver disease (AFLD)-associated HCC.

Keywords: alcoholic fatty liver disease; etiology; hepatitis viruses; hepatocellular carcinoma; metabolic syndrome; non-alcoholic fatty liver disease.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
The etiology of hepatocellular carcinoma. A variety of risk factors have been associated with the development of HCC, including hepatitis viruses, carcinogens, heredity diseases, metabolic syndrome, and fatty liver disease. The mechanisms by which these etiological factors may induce hepatocarcinogenesis mainly include p53 inactivation, inflammation, oxidative stress, and telomere shortening leading to genomic instability and activation of multiple oncogenic signaling pathways.
Figure 2
Figure 2
Molecular mechanisms involved in nonalcoholic- and alcoholic-associated HCC. High-calorie diet and excessive alcohol consumption is the major risk factor for the development of NAFLD and AFLD respectively. Despite the divergent pathogenic origin, the pathological spectra of liver injury in promoting HCC development in NAFLD and AFLD share common molecular pathways.

References

    1. International Agency for Research on Cancer. World Health Organization Cancer today (2018). Available at: https://gco.iarc.fr/today/home.
    1. Villanueva A. Hepatocellular Carcinoma. N Engl J Med (2019) 380:1450–62. 10.1056/NEJMra1713263 - DOI - PubMed
    1. Zhu RX, Seto WK, Lai CL, Yuen MF. Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region. Gut Liver (2016) 10:332–39. 10.5009/gnl15257 - DOI - PMC - PubMed
    1. Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer (2019) 144:1941–53. 10.1002/ijc.31937 - DOI - PubMed
    1. Thylur RP, Roy SK, Shrivastava A, LaVeist TA, Shankar S, Srivastava RK. Assessment of risk factors, and racial and ethnic differences in hepatocellular carcinoma. JGH Open (2020) 4:351–59. 10.1002/jgh3.12336 - DOI - PMC - PubMed

LinkOut - more resources